ProCE Banner Activity

GEMINI-1 and -2: Dual-Therapy With DTG Plus 3TC Noninferior to DTG Plus FTC/TDF in Treatment-Naive Patients at Week 48

Capsule Summary
Conference Coverage

Dual-agent regimen well tolerated with high efficacy rate and no treatment-emergent resistance.

Released: July 26, 2018

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

ProCE Banner

Supporters

Janssen

ViiV Healthcare

Partners

AIDS 2018

ProCE Banner

IAS 2018

ProCE Banner